Enkephalinase (EC 3.4.24.11) inhibitors: Protection of endogenous ANF against inactivation and potential therapeutic applications
- 31 December 1990
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 47 (15) , 1279-1297
- https://doi.org/10.1016/0024-3205(90)90192-t
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- On the size of the active site in proteases. I. PapainPublished by Elsevier ,2005
- UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diureticBiochemical and Biophysical Research Communications, 1989
- Degradation of porcine brain natriuretic peptide (pBNP-26) by endoprotease-24.11 from kidney cortical membranesBiochemical and Biophysical Research Communications, 1989
- Atrial natriuretic peptides cleaved by endopeptidase are inactive in conscious spontaneously hypertensive ratsLife Sciences, 1988
- Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segmentsLife Sciences, 1988
- Molecular cloning and amino acid sequence of rat enkephalinaseBiochemical and Biophysical Research Communications, 1987
- Removal of atrial natriuretic peptide by perfused rabbit lungsBiochemical and Biophysical Research Communications, 1986
- Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in manLife Sciences, 1986
- Binding of the bidentate inhibitor [3H]HACBO-Gly to the rat brain neutral endopeptidase “enkephalinase”Biochemical and Biophysical Research Communications, 1985
- Properties of “enkephalinase” from rat kidney: Comparison of dipeptidyl-carboxypeptidase and endopeptidase activitiesBiochemical and Biophysical Research Communications, 1982